Home » UK Says More Transparency, Not Premarket Mechanism Needed for High-Risk Devices
UK Says More Transparency, Not Premarket Mechanism Needed for High-Risk Devices
January 9, 2013
In a response to the European Commission’s proposed overhaul of medical device regulations, the UK says more transparency is needed in clinical trials and approvals, but stops short of calling for increased premarket scrutiny of high-risk devices.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor